PL2289518T3 - Środek terapeutyczny na nieswoiste zapalenie jelit - Google Patents
Środek terapeutyczny na nieswoiste zapalenie jelitInfo
- Publication number
- PL2289518T3 PL2289518T3 PL09770108T PL09770108T PL2289518T3 PL 2289518 T3 PL2289518 T3 PL 2289518T3 PL 09770108 T PL09770108 T PL 09770108T PL 09770108 T PL09770108 T PL 09770108T PL 2289518 T3 PL2289518 T3 PL 2289518T3
- Authority
- PL
- Poland
- Prior art keywords
- therapeutic agent
- inflammatory bowel
- bowel disease
- disease
- inflammatory
- Prior art date
Links
- 208000022559 Inflammatory bowel disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008162640 | 2008-06-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2289518T3 true PL2289518T3 (pl) | 2017-03-31 |
Family
ID=41444464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09770108T PL2289518T3 (pl) | 2008-06-23 | 2009-06-22 | Środek terapeutyczny na nieswoiste zapalenie jelit |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US8394793B2 (pl) |
| EP (1) | EP2289518B1 (pl) |
| JP (1) | JP5527206B2 (pl) |
| KR (1) | KR101639821B1 (pl) |
| CN (1) | CN102065864B (pl) |
| CA (1) | CA2728161C (pl) |
| CY (1) | CY1118390T1 (pl) |
| DK (1) | DK2289518T3 (pl) |
| ES (1) | ES2611483T3 (pl) |
| HR (1) | HRP20170030T1 (pl) |
| HU (1) | HUE032108T2 (pl) |
| LT (1) | LT2289518T (pl) |
| PL (1) | PL2289518T3 (pl) |
| PT (1) | PT2289518T (pl) |
| SI (1) | SI2289518T1 (pl) |
| WO (1) | WO2009157398A1 (pl) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250107951A (ko) | 2009-06-26 | 2025-07-14 | 니뽄 신야쿠 가부시키가이샤 | 결정 |
| WO2011024874A1 (ja) * | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| CN104586853A (zh) * | 2014-12-31 | 2015-05-06 | 武汉联程生物科技有限公司 | 一种用于治疗外伤性颅脑创伤的药物组合物及其制备方法 |
| SI4331607T1 (sl) * | 2015-12-02 | 2025-06-30 | Nippon Shinyaku Co., Ltd. | Trdni farmacevtski sestavek, ki vsebuje 2-{4-[n-(5,6-difenilpirazin-2-il)-n-izopropilamino]butiloksi}-n-(metilsulfonil)acetamid |
| CN109563055B (zh) * | 2016-07-29 | 2021-12-24 | 成都苑东生物制药股份有限公司 | 氨基吡嗪类化合物或盐、异构体、其制备方法及用途 |
| JOP20190204A1 (ar) | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| TWI834536B (zh) | 2017-09-28 | 2024-03-01 | 日商日本新藥股份有限公司 | 結晶 |
| CA3082009A1 (en) * | 2017-11-16 | 2019-05-23 | Nippon Shinyaku Co., Ltd. | Controlled-release preparation |
| WO2019154363A1 (zh) | 2018-02-07 | 2019-08-15 | 南京明德新药研发有限公司 | 前列环素受体受体激动剂 |
| US12427145B2 (en) | 2019-02-03 | 2025-09-30 | Innovate Therapeutics Llc | Controlled release pharmaceutical composition of Selexipag or it's active metabolite |
| BR112022007207A2 (pt) | 2019-10-23 | 2022-07-26 | Actelion Pharmaceuticals Ltd | Composição farmacêutica que compreende selexipag |
| EP4096643A1 (en) | 2020-01-31 | 2022-12-07 | Actelion Pharmaceuticals Ltd | Controlled release selexipag composition |
| TW202239408A (zh) | 2021-01-29 | 2022-10-16 | 瑞士商艾克泰聯製藥有限公司 | 包含二苯基吡𠯤衍生物的醫藥組成物 |
| TW202241425A (zh) | 2021-01-29 | 2022-11-01 | 瑞士商艾克泰聯製藥有限公司 | 用於製造二苯基吡𠯤衍生物之程序 |
| WO2023131608A1 (en) | 2022-01-04 | 2023-07-13 | Actelion Pharmaceuticals Ltd | Controlled release compositions |
| WO2023214059A1 (en) | 2022-05-06 | 2023-11-09 | Actelion Pharmaceuticals Ltd | Diphenylpyrazine compounds as prodrugs |
| WO2024017964A1 (en) | 2022-07-20 | 2024-01-25 | Actelion Pharmaceuticals Ltd | Injectable pharmaceutical composition comprising a diphenylpyrazine derivative |
| WO2024133620A1 (en) | 2022-12-22 | 2024-06-27 | Actelion Pharmaceuticals Ltd | In vitro dissolution test |
| WO2024194449A1 (en) | 2023-03-23 | 2024-09-26 | Actelion Pharmaceuticals Ltd | Pharmaceutical composition comprising a diphenylpyrazine derivative |
| WO2025196095A1 (en) | 2024-03-20 | 2025-09-25 | Actelion Pharmaceuticals Ltd | Injectable pharmaceutical composition for treating pulmonary hypertension |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AUPO440696A0 (en) * | 1996-12-30 | 1997-01-23 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| TWI316055B (pl) * | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| US7326716B2 (en) | 2003-06-06 | 2008-02-05 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| US7101906B2 (en) | 2004-11-16 | 2006-09-05 | Allergan, Inc. | 2,3,4-substituted cyclopentanones as therapeutic agents |
| USRE46364E1 (en) * | 2008-02-28 | 2017-04-11 | Nippon Shinyaku Co., Ltd. | Fibrosis inhibitor |
-
2009
- 2009-06-22 US US13/000,791 patent/US8394793B2/en active Active
- 2009-06-22 EP EP09770108.0A patent/EP2289518B1/en active Active
- 2009-06-22 JP JP2010517993A patent/JP5527206B2/ja active Active
- 2009-06-22 HR HRP20170030TT patent/HRP20170030T1/hr unknown
- 2009-06-22 DK DK09770108.0T patent/DK2289518T3/en active
- 2009-06-22 ES ES09770108.0T patent/ES2611483T3/es active Active
- 2009-06-22 PL PL09770108T patent/PL2289518T3/pl unknown
- 2009-06-22 SI SI200931585A patent/SI2289518T1/sl unknown
- 2009-06-22 PT PT97701080T patent/PT2289518T/pt unknown
- 2009-06-22 WO PCT/JP2009/061287 patent/WO2009157398A1/ja not_active Ceased
- 2009-06-22 KR KR1020107028238A patent/KR101639821B1/ko active Active
- 2009-06-22 LT LTEP09770108.0T patent/LT2289518T/lt unknown
- 2009-06-22 CN CN2009801246843A patent/CN102065864B/zh active Active
- 2009-06-22 HU HUE09770108A patent/HUE032108T2/en unknown
- 2009-06-22 CA CA2728161A patent/CA2728161C/en active Active
-
2016
- 2016-12-23 CY CY20161101341T patent/CY1118390T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8394793B2 (en) | 2013-03-12 |
| JP5527206B2 (ja) | 2014-06-18 |
| WO2009157398A1 (ja) | 2009-12-30 |
| JPWO2009157398A1 (ja) | 2011-12-15 |
| CN102065864A (zh) | 2011-05-18 |
| CA2728161C (en) | 2017-06-06 |
| HUE032108T2 (en) | 2017-08-28 |
| KR20110036537A (ko) | 2011-04-07 |
| DK2289518T3 (en) | 2017-01-16 |
| PT2289518T (pt) | 2016-11-18 |
| CA2728161A1 (en) | 2009-12-30 |
| KR101639821B1 (ko) | 2016-07-14 |
| SI2289518T1 (sl) | 2017-02-28 |
| EP2289518A1 (en) | 2011-03-02 |
| LT2289518T (lt) | 2017-01-10 |
| CN102065864B (zh) | 2012-11-21 |
| HRP20170030T1 (hr) | 2017-03-24 |
| CY1118390T1 (el) | 2017-06-28 |
| EP2289518A4 (en) | 2012-04-11 |
| ES2611483T3 (es) | 2017-05-09 |
| US20110118254A1 (en) | 2011-05-19 |
| EP2289518B1 (en) | 2016-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2289518T1 (sl) | Terapevtsko sredstvo za vnetno črevesno bolezen | |
| IL207892A0 (en) | Agent for treating disease | |
| ZA201007216B (en) | Agent for treating disease | |
| IL207891A0 (en) | Agent for treating disease | |
| GB2450974B (en) | Treatment of inflammatory bowel disease with cannabinoids | |
| EP2119444A4 (en) | THERAPEUTIC AGENT FOR PAIN | |
| PT2252148T (pt) | Métodos de tratamento da síndrome do intestino irritável | |
| PL2258395T3 (pl) | Środek terapeutyczny na zwłóknienie płuca | |
| GB0811304D0 (en) | Therapeutic agents | |
| PL2280717T3 (pl) | Środek terapeutyczny dla chorób beztlenowych | |
| ZA201005735B (en) | Methods and compositions for treating inflammatory bowel disease | |
| GB0801081D0 (en) | Therapeutic agents | |
| GB0801080D0 (en) | Therapeutic agents | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| GB0805818D0 (en) | Therapeutic agents | |
| IL255052A0 (en) | Treatment of inflammatory bowel diseases by 6-mercaptopurine | |
| GB0720976D0 (en) | Treatment of inflammatory disease | |
| GB0900484D0 (en) | Therapeutic agent | |
| EP2601954A4 (en) | THERAPEUTIC FOR DISEASES | |
| EP2543388A4 (en) | MEDICINAL PRODUCT FOR INFLAMMATORY ENDURANCE | |
| EP2210878A4 (en) | THERAPEUTIC AGENT AGAINST TRPV1-MEDIATED DISEASES | |
| EP2454276A4 (en) | THERAPEUTIC AGENTS | |
| ZA201007839B (en) | Therapeutic agent for pain | |
| EP1941874A4 (en) | THERAPEUTIC MEANS FOR DELIVERY IN THE COLON AGAINST INFLAMMATORY ENDURANCE | |
| GB0915348D0 (en) | Efficient therapy for subjects with inflammatory bowel diseases |